Schedule 13G ownership disclosure

ENDRA LIFE SCIENCES INC

Common Stock, par value $0.0001 per share · CUSIP: 29273B302

Event date: 2024-12-31

Filing-level shares
35,589.00
Percent of class
6.22%
  • L1 Capital Global Opportunities Master Fund, Ltd.

    Shares: 35,589.00 · Class: 6.22%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001079973-25-000276
Form type
SCHEDULE 13G/A
Filer
ENDRA Life Sciences Inc.
CIK
CIK 1681682
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub